Finerenone may benefit CKD patients beyond those with type 2 diabetes currently approved for treatment The drug slows kidney function decline and reduces risks of kidney failure and heart complications Studies show finerenone lowers risk of kidney disease progression by 24% and cardiovascular death by 20%